Rosuvastatin for Preventing Complications in Renal Ablation

Summary

The primary objective of this study is to test the hypothesis that twice overnight high-dose rosuvastatin loading before RNA followed by 3-month treatment with regular doses of rosuvastatin can reduce both the acute and late renal artery damage.

Timeline

Start

2014-01

Primary completion

2016-12

Completion

2017-12

Drugs

Indications